You are here

obesity

Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up

BioSpace

Mon, 05/6/24 - 11:33 am

Boehringer Ingelheim

type 2 diabetes

clinical trials

Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

Motley Fool

Sun, 05/5/24 - 11:40 pm

Amgen 'encouraged' by weight-loss drug interim data, shares jump

Reuters

Thu, 05/2/24 - 10:19 pm

clinical trials

Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss

Fierce Biotech

Thu, 05/2/24 - 10:14 pm

Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans

Fierce Biotech

Wed, 05/1/24 - 11:14 pm

How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk

Yahoo Finance

Tue, 04/30/24 - 08:56 am

Why the obesity drug market is about to get a lot more crowded

Medical Marketing and Media

Fri, 04/26/24 - 11:49 am

Key opinion leaders on GLP-1 receptor agonist clinical trial design

Clinical Trials Arena

Fri, 04/26/24 - 11:41 am

clinical trials

type 2 diabetes

Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo

BioPharma Dive

Thu, 04/18/24 - 11:08 am

US to see surge in new obesity drug launches in next five years

Biopharma Reporter

Tue, 04/16/24 - 10:11 pm

European regulators find no evidence of link between new obesity medicines and suicidal thoughts

Stat

Fri, 04/12/24 - 11:09 am

Brand managers reflect on historic launch of Wegovy

Medical Marketing and Media

Mon, 04/8/24 - 12:01 pm

brand management

Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy

BioSpace

Thu, 03/28/24 - 11:22 am

Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds

Stat

Thu, 03/28/24 - 11:19 am

aspiration pneumonia

Viking touts promising phase I data for weight-loss pill candidate

BioSpace

Tue, 03/26/24 - 11:35 am

Viking Therapeutics

clinical trials

Medicare Likely to Negotiate Prices for Obesity Drugs in Next Few Years: CBO

BioSpace

Thu, 03/21/24 - 11:18 am

Is Novo Nordisk on the Verge of Another Blockbuster Drug?

Motley Fool

Tue, 03/19/24 - 11:25 am

Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?

Motley Fool

Fri, 03/15/24 - 11:13 am

Viking Therapeutics

Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity

Drugs.com

Sun, 03/10/24 - 08:28 pm

Regor Therapeutics

clinical trials

Novo Nordisk confident of amycretin obesity drug launch this decade

Reuters

Fri, 03/8/24 - 11:09 am

Pages